Publications by authors named "Amale Chebib"

Claim this Profile
M
Multiple Myeloma in Patients over 80: A Real World Retrospective Study of First Line Conservative Approach with Bortezomib Dexamethasone Doublet Therapy and Mini-Review of Literature.
Laurence Huynh, Rudy Birsen, Lucie Mora, Anne-Laure Couderc, Nathalie Mitha, Amale Chebib

Cancers (Basel)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective study of patient-tailored FOLFIRINOX as a first-line chemotherapy for patients with advanced biliary tract cancer.
Ayhan Ulusakarya, Abdoulaye Karaboué, Oriana Ciacio, Gabriella Pittau, Mazen Haydar, Amale Chebib

BMC Cancer· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-tailored FOLFIRINOX as first line treatment of patients with advanced pancreatic adenocarcinoma.
Ayhan Ulusakarya, Nahla Teyar, Abdoulaye Karaboué, Mazen Haydar, Sarra Krimi, Amale Chebib

Medicine (Baltimore)· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of geriatric consultation with comprehensive geriatric assessment on final therapeutic decision in elderly cancer patients.
Pascal Chaïbi, Nicolas Magné, Sylvie Breton, Amale Chebib, Sarah Watson

Crit Rev Oncol Hematol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Geriatric oncology: epidemiological evidence].
François Piette, Jean-Philippe Spano, Pascal Chaibi, Cécile Legendre, Shuy-Vang Toan, Amale Chebib

Presse Med· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined paclitaxel and cetuximab achieved a major response on the skin metastases of a patient with epidermal growth factor receptor-positive, estrogen receptor-negative, progesterone receptor-negative and human epidermal growth factor receptor-2-negative (triple-negative) breast cancer.
Dany Gholam, Amale Chebib, Dominique Hauteville, Marie-Pierre Bralet, Claude Jasmin

Anticancer Drugs· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis